Related references
Note: Only part of the references are listed.Orexin Receptor Antagonists Differ from Standard Sleep Drugs by Promoting Sleep at Doses That Do Not Disrupt Cognition
Jason M. Uslaner et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Discovery of [(2R,5R)-5-{[(5-Fluoropyridin-2-yl)oxy]methyl}-2-methylpiperidin-1-yl][5-methyl-2-(pyrimidin-2-yl)phenyl]methanone (MK-6096): A Dual Orexin Receptor Antagonist with Potent Sleep-Promoting Properties
Paul J. Coleman et al.
CHEMMEDCHEM (2012)
Functional and binding kinetic studies make a distinction between OX1 and OX2 orexin receptor antagonists
Stefania Faedo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Orexin receptor antagonism for treatment of insomnia A randomized clinical trial of suvorexant
W. Joseph Herring et al.
NEUROLOGY (2012)
Pharmacological characterization of MK-6096-A dual orexin receptor antagonist for insomnia
Christopher J. Winrow et al.
NEUROPHARMACOLOGY (2012)
Differential Effects of a Dual Orexin Receptor Antagonist (SB-649868) and Zolpidem on Sleep Initiation and Consolidation, SWS, REM Sleep, and EEG Power Spectra in a Model of Situational Insomnia
Paolo Bettica et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Dual Hypocretin Receptor Antagonism Is More Effective for Sleep Promotion than Antagonism of Either Receptor Alone
Stephen R. Morairty et al.
PLOS ONE (2012)
International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin Receptor Function, Nomenclature and Pharmacology
Anthony L. Gotter et al.
PHARMACOLOGICAL REVIEWS (2012)
Discovery process and pharmacological characterization of a novel dual orexin 1 and orexin 2 receptor antagonist useful for treatment of sleep disorders
Romano Di Fabio et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Promotion of Sleep by Suvorexant--A Novel Dual Orexin Receptor Antagonist
Christopher J. Winrow et al.
JOURNAL OF NEUROGENETICS (2011)
Differential Effects of the Dual Orexin Receptor Antagonist Almorexant and the GABAA-α1 Receptor Modulator Zolpidem, Alone or Combined with Ethanol, on Motor Performance in the Rat
Michel A. Steiner et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia
Christopher D. Cox et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Antagonism of rat orexin receptors by almorexant attenuates central chemoreception in wakefulness in the active period of the diurnal cycle
Aihua Li et al.
JOURNAL OF PHYSIOLOGY-LONDON (2010)
Sex differences and the effect of gaboxadol and zolpidem on EEG power spectra in NREM and REM sleep
D. J. Dijk et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Blockade of Orexin-1 Receptors Attenuates Orexin-2 Receptor Antagonism-Induced Sleep Promotion in the Rat
Christine Dugovic et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Biochemical and Electrophysiological Characterization of Almorexant, a Dual Orexin 1 Receptor (OX1)/Orexin 2 Receptor (OX2) Antagonist: Comparison with Selective OX1 and OX2 Antagonists
Pari Malherbe et al.
MOLECULAR PHARMACOLOGY (2009)
The Role of Imaging in Proof of Concept for CNS Drug Discovery and Development
Dean F. Wong et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Promotion of sleep by targeting the orexin system in rats, dogs and humans
Catherine Brisbare-Roch et al.
NATURE MEDICINE (2007)
Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice
M Mieda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Increased hypocretin-1 (orexin-a) levels in cerebrospinal fluid of rats after short-term forced activity
PJF Martins et al.
REGULATORY PEPTIDES (2004)
Sub-chronic administration of zolpidem affects modifications to rat sleep architecture
JJ Renger et al.
BRAIN RESEARCH (2004)
Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice:: Molecular genetic dissection of non-REM and REM sleep regulatory processes
JT Willie et al.
NEURON (2003)
Increased CSF hypocretin-1 (orexin-A) in restless legs syndrome
RP Allen et al.
NEUROLOGY (2002)
To eat or to sleep? Orexin in the regulation of feeding and wakefulness
JT Willie et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats
DC Piper et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
Diurnal variation in orexin A immunoreactivity and prepro-orexin mRNA in the rat central nervous system
S Taheri et al.
NEUROSCIENCE LETTERS (2000)
Hypocretin (orexin) deficiency in human narcolepsy
S Nishino et al.
LANCET (2000)
Share Paper
